fda compounding semaglutide news november 2025 Novo Nordisk expands legal action to protect US patients from unsafe, non- FDA-approved compounded "semaglutide" Drug compounders sue FDA over
Description
Bergman M
While the evidence is not yet definitive, some researchers suggest that long-term exposure to GLP-1 drugs could potentially influence the activity of the guts L-cells the cells responsible for producing natural GLP-1 and related hormones such as GLP-2, which helps maintain the integrity of the intestinal lining
In simple terms, it amplifies that internal message
And while the condition is called Ozempic blindness, its not just about Ozempic
